MedTrace Logo

Smoking Cessation Effect of Tea Filter Through Inhibition of Nicotine Receptor

NCT00971529 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 159

Last updated 2009-09-04

No results posted yet for this study

Summary

Cigarette smoking is the major risk factor for a series of life threatening diseases including cancer and heart attack, which causes millions of deaths each year worldwide. Many of the harmful effects of cigarette smoking can be reversed by quitting; however, due to the addictive nature of nicotine, quitting smoking is extremely difficult. Despite the efforts, currently available methods produce only modest smoking cessation rates with relapse. Previously, tea components were shown to protect effect against cigarette smoke-induced toxicity. Here the investigator reported an unprecedented smoking cessation effect of tea. Green tea was made into cigarette filters and tested for its smoking cessation effect in a double-blind clinical study. The tea filter could effectively achieve abstinence relapse using smoking process to quite smoking and easy to be used by smoker without any side effects and psychological obstacles. This work provides a new idea and innovative method to combat tobacco epidemic. Its implementation and popularization may make a great contribution towards to reducing the smoking-related diseases, and relieving the public health burden and pollution caused by cigarette smoking.

Conditions

  • Tobacco Cessation

Sponsors & Collaborators

  • Chinese Academy of Sciences

    collaborator OTHER_GOV

  • General Hospital of Beijing PLA Military Region

    lead OTHER

Principal Investigators

  • Ran Tao, MD · Addiction Branch, Beijing Military Reneral Hospital

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-01-31
Primary Completion
2009-05-31
Completion
2009-07-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00971529 on ClinicalTrials.gov